Matsuda, Yutaka
Ajinomoto Co., Inc.
3 papers on CoChatORCID 0000-0003-2801-4706
Most cited papers
- Verified
Enhanced Inhibition of ERK Signaling by a Novel Allosteric MEK Inhibitor, CH5126766, That Suppresses Feedback Reactivation of RAF Activity
Ishii, N., Harada, N., Joseph, E. W., Ohara, K., Miura, T., Sakamoto, H., Matsuda, Y., Tomii, Y., Tachibana-Kondo, Y., Iikura, H., et al. (2013) · Cancer Research
Melanoma and MAPK PathwaysProtein Kinase Regulation and GTPase Signaling
Cited by 179
- Verified
Bispecific Antibodies Produced via Chemical Site-Specific Conjugation Technology: AJICAP Second Generation
Fujii, T., Ito, K., Takahashi, K., Aoki, T., Seki, T., Iwai, Y., Takasugi, R., Watanabe, T., Hirama, R., Tsumura, R., et al. (2023) · ACS Medicinal Chemistry Letters
Monoclonal and Polyclonal Antibodies ResearchChemical Synthesis and Analysis
Cited by 12
- Verified
A Manufacturing Strategy Utilizing a Continuous-Mode Reactor toward Homogeneous PEGylated Bioconjugate Production
Nakahara, Y., Endo, Y., Matsuda, Y., Nagaki, A., Takahashi, K., Kawaguchi, T., & Kato, K. (2024) · Synthesis
Protein purification and stabilityInnovative Microfluidic and Catalytic Techniques Innovation
Cited by 5
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free